Showing results (331-340 of 378) with videos related to

Sort By:
Pageof 38
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Leukemia|April 17, 2013
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implicationsY-T Tai, Y Landesman, C Acharya, et al.
Nature Biotechnology|March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell linesChanning Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Cancer Cell|July 12, 2011
Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitorScott R Daigle, Edward J Olhava, Carly A Therkelsen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2017
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategyAlanna J Church, Monica L Calicchio, Valentina Nardi, et al.
Blood|November 23, 2006
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myelomaYazan Alsayed, Hai Ngo, Judith Runnels, et al.
Molecular Cancer Therapeutics|September 5, 2025
Anti-tumor activity of trastuzumab deruxtecan in pediatric solid tumors with variable HER2 expressionChelsey M Burke, Tamar Y Feinberg, Samantha Brosius, et al.
Genome Medicine|December 24, 2016
Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterationsJennifer A Oberg, Julia L Glade Bender, Maria Luisa Sulis, et al.
Blood|January 14, 2009
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapyAbdel Kareem Azab, Judith M Runnels, Costas Pitsillides, et al.
Clinical Transplantation|April 28, 2025
Rethinking the Diagnosis and Management of Antibody-Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group RecommendationsRuth Sapir-Pichhadze, Medhat Askar, Matthew Cooper, et al.
Pageof 38